Edesa Biotech Statistics

Total Valuation

Edesa Biotech has a market cap or net worth of $16.57 million. The enterprise value is $15.01 million.

Market Cap	16.57M
Enterprise Value	15.01M

Important Dates

The next estimated earnings date is Friday, May 9, 2025, after market close.

Earnings Date	May 9, 2025
Ex-Dividend Date	n/a

Share Statistics

Edesa Biotech has 7.02 million shares outstanding. The number of shares has increased by 8.96% in one year.

Current Share Class	7.02M
Shares Outstanding	7.02M
Shares Change (YoY)	+8.96%
Shares Change (QoQ)	+3.00%
Owned by Insiders (%)	8.20%
Owned by Institutions (%)	1.55%
Float	4.95M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	6.38
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.09

Current Ratio	1.09
Quick Ratio	1.01
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -150.67% and return on invested capital (ROIC) is -107.73%.

Return on Equity (ROE)	-150.67%
Return on Assets (ROA)	-73.52%
Return on Invested Capital (ROIC)	-107.73%
Return on Capital Employed (ROCE)	-311.67%
Revenue Per Employee	n/a
Profits Per Employee	-$381,803
Employee Count	16
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Edesa Biotech has paid $800 in taxes.

Income Tax	800
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -45.24% in the last 52 weeks. The beta is 0.60, so Edesa Biotech's price volatility has been lower than the market average.

Beta (5Y)	0.60
52-Week Price Change	-45.24%
50-Day Moving Average	2.37
200-Day Moving Average	3.07
Relative Strength Index (RSI)	51.84
Average Volume (20 Days)	8,968

Short Selling Information

The latest short interest is 54,514, so 0.78% of the outstanding shares have been sold short.

Short Interest	54,514
Short Previous Month	73,064
Short % of Shares Out	0.78%
Short % of Float	1.10%
Short Ratio (days to cover)	2.02

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-7.06M
Pretax Income	-6.93M
Net Income	-6.11M
EBITDA	-6.95M
EBIT	-7.06M
Earnings Per Share (EPS)	-$1.88

Full Income Statement

Balance Sheet

The company has $1.56 million in cash and n/a in debt, giving a net cash position of $1.56 million or $0.22 per share.

Cash & Cash Equivalents	1.56M
Total Debt	n/a
Net Cash	1.56M
Net Cash Per Share	$0.22
Equity (Book Value)	2.26M
Book Value Per Share	0.37
Working Capital	171,709

Full Balance Sheet

Cash Flow

Operating Cash Flow	-5.00M
Capital Expenditures	n/a
Free Cash Flow	-5.00M
FCF Per Share	-$0.71

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Edesa Biotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-8.96%
Shareholder Yield	-8.96%
Earnings Yield	-36.86%
FCF Yield	-30.17%

Analyst Forecast

The average price target for Edesa Biotech is $21.00, which is 789.83% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$21.00
Price Target Difference	789.83%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on October 11, 2023. It was a reverse split with a ratio of 0.1428571:1.

Last Split Date	Oct 11, 2023
Split Type	Reverse
Split Ratio	0.1428571:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1